Condition: Lewy Body Dementia · Dementia With Lewy Bodies · Parkinson's Disease Dementia · Sponsor: Axovant Sciences Ltd.
This study seeks to evaluate the long-term safety and effectiveness of nelotanserin for the treatment of visual hallucinations (VHs) and Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) in subjects with Lewy body dementia (LBD).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| US120 | Birmingham, Alabama, United States | — |
| US143 | Little Rock, Arkansas, United States | — |
| US114 | Boca Raton, Florida, United States | — |
| US180 | Maitland, Florida, United States | — |
| US154 | Ocala, Florida, United States | — |
| US113 | Orlando, Florida, United States | — |
| US152 | Ormond Beach, Florida, United States | — |
| US107 | Indianapolis, Indiana, United States | — |
| US132 | Lenexa, Kansas, United States | — |
| US103 | Rochester, Minnesota, United States | — |
| US129 | Lincoln, Nebraska, United States | — |
| US101 | Chapel Hill, North Carolina, United States | — |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02871427